SOD1 and breast cancer: In contrast, previous analysis in plasma (12,39,47), erythrocytes, and whole blood (41,43,48) of women with breast cancer showed decreased SOD, CAT, and GPx activity, being therefore insufficient for antioxidant protection (43,49).